Eosinophilic cellulitis (Wells' syndrome) successfully treated with low-dose cyclosporine

Journal of Korean Medical Science

Volumn 16, Issue 5, 2001, Pages 664-668

  Herr, Hwan ^a,b   Koh, Jai Kyoung ^b  

^a Asan Kangnung Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Cellulitis; Cyclosporine; Eosinophilic Cellulitis (Wells' Syndrome)

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CELLULITIS; EOSINOPHILIA; HUMAN; MALE;

ADULT; CELLULITIS; CYCLOSPORINE; EOSINOPHILIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 0035487996     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.5.664     Document Type: Article

References (33)

1. Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc 1971; 57: 46-56.
2. Wells GC, Smith NP. Eosinophilic cellulitis. Br J Dermatol 1979; 100: 101-9.
3. Aberer W, Konrad K, Wolff K. Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol 1988; 18: 105-14.
4. Goh CL. Eosinophilic cellulitis (Wells' syndrome). Int J Dermatol 1992; 31: 429-30.
5. Brehmer-Andersson E, Kaaman T, Skog E, Frithz A. The histopathogenesis of the flame figure in Wells' syndrome based on five cases. Acta Derm Venereol (Stockh) 1986; 66: 213-9.
6. Wood C, Miller AC, Jacobs A, Hart R, Nickoloff BJ. Eosinophilic infiltration with flame figures. Am J Dermatopathol 1986; 8: 186-93.
7. Thomson AW, Milton JI, Aldridge RD, Davidson RJ, Simpson JG. Inhibition of drug-induced eosinophilia by cyclosporin A. Scand J Immunol 1986; 24: 163-70.
8. Zabel P, Schlaak M. Cyclosporin for hypereosinophilic syndrome. Ann Hematol 1991; 62: 230-1.
9. Akiyama Y, Shimizu A, Kimura A, Onodera R, Minatani M, Horikoshi K, Jingu K, Fukakusa M, Kotajima F, Sato T. Successful treatment of hypereosinophilic syndrome with cyclosporin and steroids. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35: 541-5.
10. Clauw DJ, Alloway JA, Katz P. Use of cyclosporin A in the eosinophilia myalgia syndrome. Ann Rheum Dis 1993; 52: 81-2.
11. Taniguchi S, Tsuruta D, Hamada T. Eosinophilic pustular folliculitis responding to cyclosporin [letter]. Br J Dermatol 1994; 131: 736-8.
12. Valencia IC, Chang A, Kirsner RS, Kerdel FA. Eosinophilic fasciitis responsive to treatment with pulsed steroids and cyclosporine. Int J Dermatol 1999; 38: 369-72.
13. Hayashi N, Igarashi A, Matsuyama T, Harada S. Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin [letter]. Br J Dermatol 2000; 142: 830-2.
14. Kaneko K, Aoki M, Hattori S, Sato M, Kawana S. Successful treatment of Kimura's disease with cyclosporine. J Am Acad Dermatol 1999; 41: 893-4.
15. Andreano JM, Kantor GR, Bergfeld WF, Tuthill RJ, Taylor JS. Eosinophilic cellulitis and eosinophilic pustular folliculitis. J Am Acad Dermatol 1989; 20: 934-6.
16. Coldiron BM, Robinson JK. Low-dose alternate-day prednisone for persistent Wells' syndrome. Arch Dermatol 1989; 125: 1625-6.
17. Leiferman KM. A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol 1991; 24: 1101-12.
18. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79: 3101-9.
19. Espana A, Sanz ML, Sola J, Gil P. Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol 1999; 140: 127-30.
20. Yagi H, Tokura Y, Matsushita K, Hanaoka K, Furukawa F, Takigawa M. Wells' syndrome: a pathogenic role for circulating CD4+ CD7- T cells expressing interleukin-5 mRNA. Br J Dermatol 1997; 136: 918-23.
21. Plotz SG, Abeck D, Behrendt H, Simon HU, Ring J. Eosinophilic cellulitis (Wells' syndrome). Hautarzt 2000; 51: 182-6.
22. Lee MW, Nixon RL. Eosinophilic cellulitis case report: treatment options. Australas J Dermatol 1994; 35: 95-7.
23. Stam-Westerveld EB, Daenen S, Van der Meer JB, Jonkman MF. Eosinophilic cellulitis (Wells' syndrome): treatment with minocycline [letter]. Acta Derm Venereol 1998; 78: 157.
24. Diridl E, Honigsmann H, Tanew A. Wells' syndrome responsive to PUVA therapy [letter]. Br J Dermatol 1997; 137: 479-81.
25. Hess AD, Esa AH, Colombani PM. Mechanism of action of cyclosporin: effects on cells of the immune system and on subcellular events in T cell activation. Transplant Proc 1988; 20(Supple 2): 29-40.
26. Teixeira MM, Williams TJ, Hellewell PG. Effects of dexamethasone and cyclosporin A on the accumulation of eosinophils in acute cutaneous inflammation in the guinea-pig. Br J Pharmacol 1996; 118: 317-24.
27. Wada K, Kaminuma O, Mori A, Nakata A, Ogawa K, Kikkawa H, Ikezawa K, Suko M, Okudaira H. IL5-producing T cells that induce airway eosinophilia and hyperresponsiveness are suppressed by dexamethasone and cyclosporin A in mice. Int Arch Allergy Immunol 1998; 117(suppl): 24-7.
28. Mori A, Kaminuma O, Ogawa K, Nakata A, Egan RW, Akiyama K, Okudaira H. Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors. J Allergy Clin Immunol 2000; 106S: 58-64.
29. Bogenrieder T, Griese DP, Schiffner R, Buttner R, Riegger GA, Hohenleutner U, Landthaler M. Wells' syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol 1997; 137: 978-82.
30. Lee SC, Shin SS, Lee JB, Won YH. Wells syndrome associated with Churg-Strauss syndrome [letter]. J Am Acad Dermatol 2000; 43: 556-7.
31. Lim KK, Su WP, Schroeter AL, Sabers CJ, Abraham RT, Pittelkow MR. Cyclosporine in the treatment of dermatologic diseases: an update. Mayo Clin Proc 1996; 71: 1182-91.
32. Feutren G, Mihatsch M. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654-60.
33. Dutz JP, Ho VC. Immunosuppressive agents in dermatology: an update: cyclosporine. Dermatol Clin 1998; 16: 235-51.